Literature DB >> 12915239

Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone).

Per Lundgren1, Jessica Strömberg, Torbjörn Bäckström, Mingde Wang.   

Abstract

Altered gamma-aminobutyric acid (GABA)-ergic function is associated with neurological and psychiatric disorders. Certain progesterone metabolite 3alpha-hydroxy-5alpha-pregnan-20-one, or allopregnanolone (ALLO), increases the GABA-mediated chloride ion (Cl(-)) flux through GABA(A) receptors in a similar fashion as benzodiazepines and barbiturates. We have studied the effect of its 3beta diastereomer, 3beta-hydroxy-5alpha-pregnan-20-one, or isoallopregnanolone (ISO), on the Cl(-) flux and investigated the interaction between ISO and ALLO on GABA-mediated Cl(-) uptake in cortical homogenates from adult male Wistar rats. We found that ISO from 1 microM to 1 mM does not affect baseline Cl(-) uptake in rat cortical homogenates. Neither does ISO at dose range of 100 nM to 100 microM interact with 10 microM GABA in the Cl(-) uptake assay. In addition, ISO at the dose range of 1-30 microM does not affect flunitrazepam and pentobarbital-induced increase of Cl(-) uptake. We conclude that ISO selectively inhibits the ALLO-induced Cl(-) uptake with respect to ALLO concentrations. The IC(50) of ISO inhibition on 1 microM ALLO-induced Cl(-) uptake was calculated to be 12.25 microM. On the other hand, we have studied the effect of 30 microM ISO on ALLO (0.01 nM to 1 microM) induced displacement of tert-butylbicyclophosphorothionate (TBPS) binding. We did not note any interaction between ALLO and ISO on TBPS binding assay. These results indicate that ISO may be useful functional blocker of GABA(A) receptor potentiating steroid ALLO when used at concentrations that do not affect baseline GABAergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915239     DOI: 10.1016/s0006-8993(03)02939-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.

Authors:  Roberto Cosimo Melcangi; Donatella Caruso; Giovanna Levandis; Federico Abbiati; Marie-Therese Armentero; Fabio Blandini
Journal:  J Mol Neurosci       Date:  2011-06-14       Impact factor: 3.444

Review 2.  GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

Authors:  Torbjörn Bäckström; Marie Bixo; Jessica Strömberg
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

3.  Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.

Authors:  Shanna Babalonis; Joshua A Lile; Catherine A Martin; Thomas H Kelly
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD.

Authors:  Ann M Rasmusson; Matthew W King; Ivan Valovski; Kristin Gregor; Erica Scioli-Salter; Suzanne L Pineles; Mohamed Hamouda; Yael I Nillni; George M Anderson; Graziano Pinna
Journal:  Psychoneuroendocrinology       Date:  2018-11-22       Impact factor: 4.905

5.  Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty.

Authors:  Hui Shen; Qi Hua Gong; Chiye Aoki; Maoli Yuan; Yevgeniy Ruderman; Michael Dattilo; Keith Williams; Sheryl S Smith
Journal:  Nat Neurosci       Date:  2007-03-11       Impact factor: 24.884

6.  Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissues.

Authors:  Olga V Belyaeva; Sergei V Chetyrkin; Amy L Clark; Natalia V Kostereva; Karen S SantaCruz; Bibie M Chronwall; Natalia Y Kedishvili
Journal:  Endocrinology       Date:  2007-02-08       Impact factor: 4.736

7.  Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.

Authors:  Helena Hedström; Marie Bixo; Sigrid Nyberg; Olav Spigset; Elisabeth Zingmark; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

8.  A 17beta-derivative of allopregnanolone is a neurosteroid antagonist at a cerebellar subpopulation of GABA A receptors with nanomolar affinity.

Authors:  G Maksay; L Fodor; T Bíró; N Avlonitis; T Calogeropoulou
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

9.  Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.

Authors:  Donatella Caruso; Samuele Scurati; Ilaria Roglio; Lucilla Nobbio; Angelo Schenone; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2008-01-09       Impact factor: 3.444

10.  Puberty, steroids and GABA(A) receptor plasticity.

Authors:  Sheryl S Smith; Chiye Aoki; Hui Shen
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.